CC — Chemours Co Income Statement
0.000.00%
Last trade - 00:00
- $4.07bn
- $6.90bn
- $6.03bn
- 49
- 54
- 52
- 50
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,526 | 4,969 | 6,345 | 6,794 | 6,027 |
Cost of Revenue | |||||
Gross Profit | 1,063 | 1,067 | 1,381 | 1,616 | 1,306 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5,178 | 4,624 | 5,690 | 6,015 | 6,273 |
Operating Profit | 348 | 345 | 655 | 779 | -246 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -124 | 179 | 676 | 741 | -318 |
Provision for Income Taxes | |||||
Net Income After Taxes | -52 | 219 | 608 | 578 | -237 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -52 | 219 | 608 | 578 | -238 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -52 | 219 | 608 | 578 | -238 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.69 | 1.88 | 4.49 | 4.71 | 1.98 |
Dividends per Share |